BioCentury
ARTICLE | Clinical News

Coley starts Phase II study in asthma

October 19, 2000 7:00 AM UTC

Coley Pharmaceutical (Wellesley, Mass.) began U.K. Phase II testing of its CpG immune modulator in 24 patients with allergic asthma who are sensitive to a dust mite allergen. Primary end points includ...